Search research articles
Contact Us
Filters
Showing results (51-60 of 107) with videos related to
Page
of 11
Sort By:
Journal of Hepatology
|
January 18, 2018
Reply to: "Reply to: 'Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries'"
Ana da Silva Filipe, Vattipally Sreenu, Joseph Hughes, et al.
Viruses
|
August 26, 2022
Characterisation of a Hepatitis C Virus Subtype 2a Cluster in Scottish PWID with a Suboptimal Response to Glecaprevir/Pibrentasvir Treatment
Rajiv Shah, Stephen T Barclay, Erica S Peters, et al.
The Journal of Infectious Diseases
|
March 5, 2021
Real-World Outcomes of Direct-Acting Antiviral Treatment and Retreatment in United Kingdom-Based Patients Infected With Hepatitis C Virus Genotypes/Subtypes Endemic in Africa
Elihu Aranday-Cortes, C Patrick McClure, Christopher Davis, et al.
Elife
|
June 29, 2021
Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data
Oliver Stirrup, Joseph Hughes, Matthew Parker, et al.
The Journal of Infectious Diseases
|
July 25, 2024
Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in Fatal COVID-19
Jasmin K Sidhu, Matthew K Siggins, Felicity Liew, et al.
Nature Communications
|
October 29, 2010
B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection
Kuan-Hsiang G Huang, David Bonsall, Aris Katzourakis, et al.
Viruses
|
April 17, 2019
Interpreting Viral Deep Sequencing Data with GLUE
Joshua B Singer, Emma C Thomson, Joseph Hughes, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
August 22, 2019
Development of a World Health Organization International Reference Panel for different genotypes of hepatitis E virus for nucleic acid amplification testing
Sally A Baylis, Kay-Martin O Hanschmann, Keiji Matsubayashi, et al.
The Lancet. Global Health
|
October 18, 2025
Causes, associated exposures, and outcomes of cirrhosis and hepatocellular carcinoma in Malawi: an observational cohort and case-control study
Alexander J Stockdale, Benno Kreuels, Isaac T Shawa, et al.
Journal of Viral Hepatitis
|
May 18, 2021
Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy
David A Smith, Daniel Bradshaw, Jean L Mbisa, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 107) with videos related to
Sort By:
Page
of 11
Journal of Hepatology
|
January 18, 2018
Reply to: "Reply to: 'Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries'"
Ana da Silva Filipe, Vattipally Sreenu, Joseph Hughes, et al.
Viruses
|
August 26, 2022
Characterisation of a Hepatitis C Virus Subtype 2a Cluster in Scottish PWID with a Suboptimal Response to Glecaprevir/Pibrentasvir Treatment
Rajiv Shah, Stephen T Barclay, Erica S Peters, et al.
The Journal of Infectious Diseases
|
March 5, 2021
Real-World Outcomes of Direct-Acting Antiviral Treatment and Retreatment in United Kingdom-Based Patients Infected With Hepatitis C Virus Genotypes/Subtypes Endemic in Africa
Elihu Aranday-Cortes, C Patrick McClure, Christopher Davis, et al.
Elife
|
June 29, 2021
Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data
Oliver Stirrup, Joseph Hughes, Matthew Parker, et al.
The Journal of Infectious Diseases
|
July 25, 2024
Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in Fatal COVID-19
Jasmin K Sidhu, Matthew K Siggins, Felicity Liew, et al.
Nature Communications
|
October 29, 2010
B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection
Kuan-Hsiang G Huang, David Bonsall, Aris Katzourakis, et al.
Viruses
|
April 17, 2019
Interpreting Viral Deep Sequencing Data with GLUE
Joshua B Singer, Emma C Thomson, Joseph Hughes, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
August 22, 2019
Development of a World Health Organization International Reference Panel for different genotypes of hepatitis E virus for nucleic acid amplification testing
Sally A Baylis, Kay-Martin O Hanschmann, Keiji Matsubayashi, et al.
The Lancet. Global Health
|
October 18, 2025
Causes, associated exposures, and outcomes of cirrhosis and hepatocellular carcinoma in Malawi: an observational cohort and case-control study
Alexander J Stockdale, Benno Kreuels, Isaac T Shawa, et al.
Journal of Viral Hepatitis
|
May 18, 2021
Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy
David A Smith, Daniel Bradshaw, Jean L Mbisa, et al.
Page
of 11